Suppr超能文献

大动脉闭塞性急性缺血性卒中的机械取栓术——当前趋势与未来展望

Mechanical thrombectomy for AIS from large vessel occlusion - current trends and future perspectives.

作者信息

Parvathy Gauri, Dey Rohit C, Kutikuppala Lakshmi Venkata Simhachalam, Maheshwari Aakansh R, Josey Elwy, Chintala Jyothi S, Abdullah Mohammed, Godugu Swathi

机构信息

Department of Internal Medicine, Tbilisi State Medical University, Tbilisi, Georgia.

Department of Internal Medicine, Altai State Medical University, Barnaul, Russia.

出版信息

Ann Med Surg (Lond). 2023 Oct 4;85(12):6021-6028. doi: 10.1097/MS9.0000000000001385. eCollection 2023 Dec.

Abstract

Stroke is found to be one of the global top causes of mortality and the major factor in years of life with a handicap (DALYs). Ischemic strokes contributed to nearly 70% of all strokes worldwide. For endovascular thrombectomy in acute ischemic stroke with large vessel obstruction (AIS-LVO), using stent retrievers and/or reperfusion catheters has become the gold standard of therapy. The methodology involved keyword-based search in databases like PubMed, Embase, and Google Scholar for recent publications on mechanical thrombectomy (MT), AIS, large vessel occlusion (Large Vessel Occlusion (LVO)), screening relevant articles, retrieving full texts, and synthesizing key findings on procedural advancements, patient selection, COVID-19 (coronavirus disease 2019) impact, delay effects, effectiveness, clinical outcomes, and future perspectives. Only people with substantial cerebral artery obstruction may do well from MT. This includes the distal carotid artery and the proximal middle cerebral artery (segment M1). The size of a blocked vessel and NIHSS (National Institute of Health Stroke Scale) score are directly connected. Both the 2018 and 2019 versions of the AHA/ASA (American Heart Association/American Stroke Association) Guidelines for the Early Management of Patients with Acute Ischemic Stroke contained the recommendations that cases with AIS-LVO get endovascular therapy when administered during the time frame of 0-6 h after onset (Grade IA evidence). It is questionable whether this group of patients can be managed without the need for intravenous tissue plasminogen activator at the onset. When functional independence [modified Rankin Scale (mRS) score 2] was present at long-term follow-up, the endovascular intervention was favored. Tenecteplase, which differs from alteplase in terms of genetic variation, has a greater half-life and a higher level of fibrin selectivity, enabling bolus infusion. Studies have also demonstrated its efficacy and safety, as well as its long-term cost-effectiveness.

摘要

中风是全球主要死因之一,也是导致残疾调整生命年(DALYs)的主要因素。缺血性中风占全球所有中风病例的近70%。对于急性缺血性中风伴大血管闭塞(AIS-LVO)的血管内血栓切除术,使用支架取栓器和/或再灌注导管已成为治疗的金标准。该方法包括在PubMed、Embase和谷歌学术等数据库中进行基于关键词的搜索,以查找有关机械血栓切除术(MT)、AIS、大血管闭塞(LVO)的最新出版物,筛选相关文章,获取全文,并综合有关手术进展、患者选择、COVID-19(2019冠状病毒病)影响、延迟效应、有效性、临床结果和未来展望的关键发现。只有大脑动脉严重阻塞的患者可能从MT中获益。这包括颈内动脉远端和大脑中动脉近端(M1段)。阻塞血管的大小与美国国立卫生研究院卒中量表(NIHSS)评分直接相关。2018年和2019年版美国心脏协会/美国卒中协会(AHA/ASA)急性缺血性中风患者早期管理指南均建议,AIS-LVO患者在发病后0至6小时内接受血管内治疗(IA级证据)。对于这组患者在发病时是否无需静脉注射组织纤溶酶原激活剂进行治疗存在疑问。当长期随访出现功能独立[改良Rankin量表(mRS)评分为2]时,倾向于进行血管内干预。替奈普酶在基因变异方面与阿替普酶不同,半衰期更长,纤维蛋白选择性更高,可进行大剂量注射。研究还证明了其有效性和安全性以及长期成本效益。

相似文献

引用本文的文献

本文引用的文献

2
Complications of Mechanical Thrombectomy in Acute Ischemic Stroke.机械取栓治疗急性缺血性脑卒中的并发症。
Neurology. 2021 Nov 16;97(20 Suppl 2):S115-S125. doi: 10.1212/WNL.0000000000012803.
5
Stroke thrombectomy complication management.脑卒中取栓术并发症的管理。
J Neurointerv Surg. 2021 Oct;13(10):912-917. doi: 10.1136/neurintsurg-2021-017349. Epub 2021 Jun 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验